12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Monday's intraday session. Zynerba Pharmaceuticals, Taysha Gene Therapies, Virios Therapeutics, Humacyte, OKYO Pharma, and Summit Therapeutics were among the gainers, with Zynerba Pharmaceuticals leading with a 283.5% increase. On the other hand, BioXcel Therapeutics, Concord Medical Services, Science 37 Hldgs, Oncology Institute, AcelRx Pharmaceuticals, and Hillstream BioPharma were among the losers, with BioXcel Therapeutics experiencing the largest drop of 38.9%.
August 14, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioXcel Therapeutics' stock fell by 38.9% following the release of their Q2 earnings report.
The significant drop in BioXcel Therapeutics' share price is likely due to negative results in their Q2 earnings report.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Taysha Gene Therapies' shares rose by 120.41% following the release of their Q2 earnings report.
The sharp increase in Taysha Gene Therapies' share price is likely due to positive results in their Q2 earnings report.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Zynerba Pharmaceuticals' shares rose by 283.5% during Monday's session.
The significant increase in Zynerba Pharmaceuticals' share price is likely due to a positive market sentiment towards the company.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100